Fresenius Medical Care AG & Co. KGaA (FMCQF) Research

Fresenius Medical Care AG & Co. KGaA, founded in 1996 and headquartered in Bad Homburg, Germany, is a global leader in providing dialysis care and associated services. The company delivers comprehensive kidney treatment across Germany, North America, and numerous international territories. Through its extensive network of outpatient dialysis clinics, Fresenius Medical Care offers direct dialysis treatments, complemented by essential laboratory and diagnostic support. Beyond clinic-based care, it equips patients with necessary materials, training, and continuous support, including clinical monitoring, follow-up assistance, and arranging for home delivery of vital supplies. In the United States, the firm also contracts with hospitals to provide dialysis services for both hospitalized end-stage renal disease (ESRD) patients and individuals experiencing acute kidney failure. A significant portion of its operations involves the development, manufacturing, and distribution of a wide array of dialysis products. These encompass polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates (both solutions and granulates), bloodlines, renal pharmaceuticals, and water treatment systems. Additionally, the company produces non-dialysis medical products, such as acute cardiopulmonary devices and apheresis technologies. Fresenius Medical Care is also actively involved in developing, acquiring, and in-licensing renal pharmaceuticals, supplying these medications and related provisions directly to patients' homes or to dialysis clinics. Furthermore, it delivers a diverse range of specialized medical services, including vascular, cardiovascular, endovascular specialty, vascular care at ambulatory surgery centers, and physician nephrology and cardiology services. Its products are distributed to dialysis clinics, hospitals, and specialized treatment centers through a combination of direct sales, local sales forces, independent distributors, dealers, and sales agents. As of February 23, 2022, the company managed 4,171 outpatient dialysis clinics across approximately 150 countries worldwide.

Open Fresenius Medical Care AG & Co. KGaA (FMCQF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.